Natalie C. Holles

Natalie C. Holles discloses dealings in 2 companies, chiefly Third Harmonic Bio, Inc. and Day One Biopharmaceuticals, Inc. We count 4 filings; the first trade dates from 11 April 2024 and the latest from 23 April 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 23 April 2026: a transaction, in Day One Biopharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.